NEOS (MC $91 M) $60 M Cash 1 Drug approved /2 Drugs close to FDA approval targeting Billion Dollar Markets . Very attractive and unknown FDA play with HUGE upside Potential i see the fair value around $20 per share .GL NEOS Therapeutics (NEOS) Market Cap: $91 M Cash: $60 M Price $5.90 Shares Out: 16.06 M Presentation http://investors.neostx.com/phoenix.zhtml?c=254075&p=irol-presentations •Adzenys XR-ODT launched May, 2016 •Robust prescription growth since launch •22,797 total TRx through December 2, 2016 •Pipeline includes two late-stage product candidates for the treatment of ADHD •Amphetamine XR-Oral Suspension —NDA Submitted Nov 15, 2016 •Cotempla (methylphenidate) XR-ODT —NDA resubmitted Dec 20, 2016
FDA acceptance for Amphetamine XR-Oral Suspension expected this or early next Week should push the stock closer or maybe over $7 .GL •Amphetamine XR-Oral Suspension —NDA Submitted Nov 15, 2016 •Cotempla (methylphenidate) XR-ODT —NDA resubmitted Dec 20, 2016
My prediction for Monday morning it will open around $9-$9.25 or below $8.75 and fluctuation will be $8.50-$9.50 by end of the day but long term investor’s is good it can cross above $10 end of the months... I wish it will open above $10 on Monday.
